Limited high quality evidence was available:
- no randomised controlled trials were identified
- several international guidelines were identified, however these did not include high quality evidence
- three systematic reviews were identified, which were based on low-level evidence
The majority of evidence on management of women at high risk of ovarian cancer was from prospective and retrospective cohort studies (level III).